Additional studies regarding the effect of Angiopoietin/Tie2 mediators on TF expression in EVs are warranted to confirm our findings, and to identify additional therapeutic targets that regulate immunothrombosis in COVID-19 and other viral respiratory diseases. Here, TEK is linked to COVID-19.